Revolution Medicines, Inc. (RVMD) Tops Q1 EPS by 10c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q1 EPS of ($0.72), $0.10 better than the analyst estimate of ($0.82). Revenue for the quarter came in at $7.01 million versus the consensus estimate of $2.5 million.

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy
• JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight